Compass Pathways plc is a United Kingdom-based biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. Co. is engaged in the development of psilocybin treatment, in which its investigational COMP360 psilocybin is administered in conjunction with psychological support, COMP360 psilocybin treatment. COMP360 is its proprietary psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin, optimized for stability and purity. Co.'s initial focus is on treatment-resistant depression (TRD), comprising patients who are inadequately served by the current treatment paradigm. We show 1 historical shares outstanding datapoints in our CMPS shares outstanding history coverage, used to compute CMPS market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing CMPS market cap history over the course of time is important for investors
interested in comparing CMPS's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of CMPS versus a peer is one thing; comparing
CMPS market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like CMPS can fluctuate over the course of history.
With this page we aim to empower investors researching CMPS by allowing them to research the CMPS market cap history. |
Free CMPS Email Alerts:
Video: The Importance of Market Cap
